Skip to main content
. 2022 Jan 26;13(1):84. doi: 10.1038/s41419-022-04540-2

Fig. 2. The clinical significance of NR2F1-AS1 and NR2F1 was analyzed in the TCGA cohort.

Fig. 2

a Difference in expression levels of NR2F1-AS1 and NR2F1 between intestinal and diffuse GC tissues. b, c NR2F1-AS1 and NR2F1 expression level in different T-stages of GC. d, e NR2F1-AS1 and NR2F1 expression level in different Pathologic stages of GC. f Difference in expression levels of NR2F1-AS1 and NR2F1 in GC tissues with different degrees of differentiation. g, h Overexpression of NR2F1 and NR2F1-AS1 predicted poor prognosis in TCGA cohort. ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05.